Statin Use May Improve Survival for Some Blood Cancers
Widely used cholesterol-lowering medications may reduce death rate of common blood cancer (WASHINGTON—April 23, 2025) — Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-low...
Read moreHydroxyurea Effective Long Term in Children Living With SCD
Children taking hydroxyurea visited emergency department less, had fewer hospital days (WASHINGTON, April 17, 2024) — Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with s...
Read moreMenstrual Cycle May Contribute to SCD Pain Crises
Protein linked to inflammation and vaso-occlusive events is elevated in follicular phase of menstrual cycle in early study (WASHINGTON— April 9, 2025) — A marker linked to inflammation, C-reactive protein, may increase significantly durin...
Read moreASH Statement on HHS Restructure
Urging Thoughtful Reform: Prioritizing Patient Access, Innovative Research, and Hematology Progress in HHS Reorganization (WASHINGTON—March 28, 2025) – Yesterday, the Administration announced mass layoffs and wide-ranging restructuring o...
Read moreMachine Learning Program Enhances Transplant Risk Assessment in Myelofibrosis Patients
The open-access model shows that 25% of patients have 40% chance of dying within one year after transplant (WASHINGTON—March 27, 2025) — A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBM...
Read moreASH Significantly Expands Bridge Grant Eligibility
The changes offer increased opportunities and flexibility for researchers facing challenges in securing NIH funding in light of recent cutbacks to federal research support. (WASHINGTON—March 20, 2025) The American Society of Hematology (ASH) expande...
Read moreNo Scientific Link Found Between Sickle Cell Trait and Sudden Death
Expert panel’s findings refute attribution of sudden death to sickle cell trait (WASHINGTON—Jan. 30, 2025) – A systematic literature review found no evidence to support that physical exertion without rhabdomyolysis (muscle breakdo...
Read moreAmerican Society of Hematology Announces 2025 Scholar Award Recipients
ASH Scholar Award Celebrates 40 years of funding early-career hematology researchers (WASHINGTON, January 17, 2024) — The American Society of Hematology (ASH) announces the 35 recipients of its Scholar Awards for 2025. Now in its 40th ye...
Read moreBelinda Avalos, MD, Begins Term as 2025 ASH President
(WASHINGTON, Jan. 7, 2025) — Belinda Avalos, MD, professor of medicine and a senior advisor to the president of Atrium Health Levine Cancer, will serve as president of the American Society of Hematology (ASH) for a year-long term through Decemb...
Read moreHeightened Risk of Hospitalization for Blood Clots Seen in People with Long-Term Exposure to Air
Association seen regardless of participants’ smoking status and in those with no prior lung disease (WASHINGTON, Dec. 17, 2024) – People exposed to higher concentrations of three types of air pollution over a period of nearly 17 years ha...
Read more- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10